Educating the next generation of scientists in translational medicine: Focus on eye diseases

Project: Research

Research areas and keywords

UKÄ subject classification

  • Medical and Health Sciences

Description

Medicine today experiences a gap between basic research and successful clinical translation that delays establishment of urgently needed therapies. This is very clearly so in blinding retinal degenerations (RDs), where most are yet untreatable, even with a wealth of basic and pre-clinical research data available. To address this problem, transMed comprises an innovative programme to educate “translational researchers” that focuses on the bench-to-bedside development of treatments for RD.

The transMed consortium is a H2020 Marie Skłodowska-Curie Innovative Training Network, and joins four academic groups (EKUT, UNIMORE, ULUND, HI) with four non-academic and SME partners (SPPD, INCU, Oculis, PamGene), and five partner organisations (2BBB, BIOLOG, NLO, HCTC, EVI). Each transMed partner will contribute specific critical expertise to a curriculum covering all major aspects of translational research: From basic research into disease mechanisms and target definition, to drug design and development, in vitro test systems and in vivo disease models, drug delivery systems, biomarkers, good manufacturing practice, toxicological testing and pharmacokinetics, regulatory affairs, intellectual property, all the way to clinical trials and commercialisation.

transMed builds on and integrates three relevant translational projects, which are at the early pre-clinical, late pre-clinical, and early clinical stages, respectively, to provide the project’s Early Stage Researchers with the broadest possible overview.

Altogether, transMed will offer its students the opportunity to obtain a competitive PhD degree in several critical areas of biomedical research, providing for a strong employability in both the private and public sector.
AcronymtransMed
StatusActive
Effective start/end date2017/12/012021/11/30

Collaborative partners

  • Lund University
  • University of Tübingen (lead)
  • University of Modena and Reggio Emilia
  • University of Iceland
  • SP Process Development
  • Inocure SRO
  • Pamgene International
  • Oculis Iceland

Participants